Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. - Archive ouverte HAL Access content directly
Journal Articles Breast Cancer Research Year : 2011

Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.

(1) , (1) , (2) , (3) , (4) , (5) , (6) , (7) , (1, 4)
1
2
3
4
5
6
7
Diana Connolly
  • Function : Author
  • PersonId : 911209
Zhixia Yang
  • Function : Author
  • PersonId : 911210
Maria Castaldi
  • Function : Author
  • PersonId : 911211
Nichelle Simmons
  • Function : Author
  • PersonId : 911212
Maja Oktay
  • Function : Author
  • PersonId : 911213

Abstract

ABSTRACT: INTRODUCTION: Altered expression of Septin 9 (SEPT9), a septin coding for multiple isoform variants, has been observed in several carcinomas including colorectal, head and neck, ovarian and breast, compared to normal tissue. Mechanisms regulating its expression during tumor initiation and progression in vivo and the oncogenic function of its different isoforms remain elusive. METHODS: Using an integrative approach, we investigated SEPT9 at the genetic, epigenetic, mRNA, and protein levels in breast cancer. We analyzed a panel of breast cancer cell lines, human primary tumors and corresponding tumor-free areas, normal breast from reduction mammoplasty patients, as well as primary mammary gland adenocarcinomas derived from the Polyoma Virus Middle T antigen mouse model (PyMT). MCF7 clones expressing individual GFP-tagged SEPT9 isoforms were used to determine their respective intracellular distribution and affect on cell migration. RESULTS: An overall increase in gene amplification and altered expression of SEPT9 was observed during breast tumorigenesis. We identified an intragenic alternative promoter whose methylation regulates SEPT9_v3 expression. Transfection of specific GFP-SEPT9 isoforms in MCF7 cells indicates that these isoforms exhibit differential localization and affect migration rates. Additionally, the loss of an uncharacterized SEPT9 nucleolar localization is observed during tumorigenesis. CONCLUSIONS: In this study we found conserved in vivo changes of SEPT9 gene amplification and overexpression during human and mouse breast tumorigenesis. We show that DNA methylation is a prominent mechanism responsible for regulating differential SEPT9 isoform expression and that breast tumor samples exhibit distinctive SEPT9 intracellular localization. Together, these findings support the significance of SEPT9 as a promising tool in breast cancer detection and further emphasize the importance of analyzing and targeting SEPT9 isoform specific expression and function.
Fichier principal
Vignette du fichier
bcr2924.pdf (3.55 Mo) Télécharger le fichier
Vignette du fichier
BCR2924-S1.DOC (131 Ko) Télécharger le fichier
Vignette du fichier
BCR2924-S2.TIFF (484.83 Ko) Télécharger le fichier
Vignette du fichier
BCR2924-S3.TIFF (552.65 Ko) Télécharger le fichier
Vignette du fichier
BCR2924-S4.TIFF (541.18 Ko) Télécharger le fichier
Vignette du fichier
BCR2924-S5.TIFF (514.43 Ko) Télécharger le fichier
Vignette du fichier
bcr2924.xml (99.06 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Loading...

Dates and versions

inserm-00627686 , version 1 (29-09-2011)

Identifiers

Cite

Diana Connolly, Zhixia Yang, Maria Castaldi, Nichelle Simmons, Maja Oktay, et al.. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.. Breast Cancer Research, 2011, 13 (4), pp.R76. ⟨10.1186/bcr2924⟩. ⟨inserm-00627686⟩

Collections

INSERM CNRS
197 View
410 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More